drugset
drugset / Trial / NCT06068478

A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis

NCT06068478 ↗

Phase 3 Completed 472 enrolled Tasly Pharmaceutical Group Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and safety of Qingzhu Granules in the treatment of Acute Gouty Arthritis ( Damp heat pattern)

Timeline

Start
2023-11-07
Primary completion
2025-04-02
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Qingzhu Granules Unknown 6 g Oral

Indications

gout